PD-0325901

PD-0325901 

To Order Contact us: lieven@wlsolutions.be

PD 0325901
MBS132263-100mg	100mg	EUR 1065

PD 0325901
MBS132263-500mg	500mg	EUR 2775

PD 0325901
GL5463-1	1	EUR 68.9

PD 0325901
GL5463-25	25	EUR 228.1

PD 0325901
GL5463-5	5	EUR 98.4

PD 0325901
MBS696352-10mg	10mg	EUR 215

PD 0325901
MBS696352-25mg	25mg	EUR 325

PD 0325901
MBS696352-5x25mg	5x25mg	EUR 1410

EZSolution? PD-0325901, Sterile-Filtered
1990-1	each	EUR 326.4

PD-325901, Free Base (PD 0325901, MEK1/2 Inhibitor III)
MBS6061791-10mg	10(mg	EUR 255

PD-325901, Free Base (PD 0325901, MEK1/2 Inhibitor III)
MBS6061791-25mg	25mg	EUR 450

PD-325901, Free Base (PD 0325901, MEK1/2 Inhibitor III)
MBS6061791-5x25mg	5x25mg	EUR 1865

PD150606 (PD 150606; PD-150606)
MBS131512-100mg	100mg	EUR 1495

PD 312236, PD 312237 Mixture
P217850	10mg	EUR 230

PD-1/PD-L1 Inhibitor 2
B1050-25	each	EUR 679.2

PD-1/PD-L1 Inhibitor 2
B1050-5	each	EUR 242.4

PD-1/PD-L1 Inhibitor 1
B1213-25	each	EUR 679.2

PD-1/PD-L1 inhibitor 2
B6023-25	25 mg	EUR 268
Description: PD-1/PD-L1 interaction inhibitor

PD-1/PD-L1 inhibitor 2
B6023-5	5 mg	EUR 84
Description: PD-1/PD-L1 interaction inhibitor

PD-1/PD-L1 inhibitor 1
B6172-25	25 mg	EUR 278
Description: PD-1/PD-L1 interaction inhibitor

PD-1/PD-L1 inhibitor 1
B6172-5	5 mg	EUR 82
Description: PD-1/PD-L1 interaction inhibitor

PD-1/PD-L1 Inhibitor 3
B6191-1	1 mg	EUR 249
Description: PD-1/PD-L1 interaction inhibitor

PD-1/PD-L1 Inhibitor 3
B6191-5	5 mg	EUR 838
Description: PD-1/PD-L1 interaction inhibitor

PD-1/PD-L1-IN-10
T9616-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-9
T9651-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN 5
T62193-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-1g	1g	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN-25
T63329-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-17
T62501-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-14
T61929-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN 6
T61968-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-1g	1g	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN-22
T63607-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-15
T63614-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-16
T63948-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-20
T64086-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-NP19
T36900-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-9
MBS5801395-1mg	1(mg	EUR 225

PD-1/PD-L1-IN-9
MBS5801395-2mg	2mg	EUR 285

PD-1/PD-L1-IN-9
MBS5801395-5mg	5(mg	EUR 345

PD-1/PD-L1-IN-10
MBS5786462-10mg	10(mg	EUR 250

PD-1/PD-L1-IN-10
MBS5786462-2mg	2(mg	EUR 180

PD-1/PD-L1-IN-10
MBS5786462-5mg	5(mg	EUR 195

PD-1/PD-L1-IN-NP19
MBS5785098-10mg	10mg	EUR 555

PD-1/PD-L1-IN-NP19
MBS5785098-25mg	25mg	EUR 1350

PD-1/PD-L1-IN-NP19
MBS5785098-50mg	50(mg	EUR 1520

PD-1/PD-L1-IN-NP19
MBS5785098-5mg	5(mg	EUR 375

PD-1/PD-L1 inhibitor 1
MBS578522-10mg	10mg	EUR 250

PD-1/PD-L1 inhibitor 1
MBS578522-25mg	25mg	EUR 375

PD-1/PD-L1 inhibitor 1
MBS578522-2mg	2mg	EUR 160

PD-1/PD-L1 inhibitor 1
MBS578522-50mg	50mg	EUR 510

PD-1/PD-L1 inhibitor 1
MBS578522-5mg	5mg	EUR 190

PD-1/PD-L1-IN 3
HY-103048	Get quote	Ask for price
Description: PD-1/PD-L1-IN 3, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 can be used for the research of various diseases, including cancer and infectious diseases[1].

PD-1/PD-L1-IN-18
HY-145768	Get quote	Ask for price
Description: PD-1/PD-L1-IN-18 (Compound L31) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-18 blocks PD-1/PD-L1 with the IC50 of 1.054 μM. Antitumor Activity[1].

PD-1/PD-L1-IN-19
HY-145770	Get quote	Ask for price
Description: PD-1/PD-L1-IN-19 (Example 22) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-19 blocks PD-1/PD-L1 with the IC50 of 62.3 nM. PD-1/PD-L1-IN-19 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-20
HY-145771	Get quote	Ask for price
Description: PD-1/PD-L1-IN-20 (Example 21) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-20 blocks PD-1/PD-L1 with the IC50 of 5.29 nM. PD-1/PD-L1-IN-20 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-21
HY-145772	Get quote	Ask for price
Description: PD-1/PD-L1-IN-21 (Example 22) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-21 blocks PD-1/PD-L1 with the IC50 of 4.99 μM. PD-1/PD-L1-IN-21 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-22
HY-145773	Get quote	Ask for price
Description: PD-1/PD-L1-IN-22 (Example 2) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-22 blocks PD-1/PD-L1 with the IC50 of 0.732 μM. PD-1/PD-L1-IN-22 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-23
HY-145774	10 mg	EUR 4058.51
Description: PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1. PD-1/PD-L1-IN-23 is an ester proagent of L7. L7 is a benzo[c][1,2,5]oxadiazole derivative and biologically evaluated as inhibitors of PD-L1. PD-1/PD-L1-IN-23 displays significant antitumor effects in tumor models of syngeneic and PD-L1 humanized mice[1].

PD-1/PD-L1-IN-27
HY-146740	Get quote	Ask for price
Description: PD-1/PD-L1-IN-27 is a potent PD-1/PD-L1 inhibitor with an IC50 value of 134 nM. PD-1/PD-L1-IN-27 shows antitumor effects with low T cell cytotoxicity. PD-1/PD-L1-IN-27 has the ability to activate CD8+ T cells and reduces T cell exhaustion[1].

PD-1/PD-L1-IN 6
HY-130625	Get quote	Ask for price
Description: PD-1/PD-L1-IN 6 (compound A13) is a potent PD-1/PD-L1 interaction inhibitor, with an IC50 of 132.8 nM. PD-1/PD-L1-IN 6 exhibits outstanding immunoregulatory activity. PD-1/PD-L1-IN 6 significantly elevates interferon-γ secretion in a Hep3B/OS-8/hPD-L1 and CD3 T cell co-culture model, without significant toxic effect. PD-1/PD-L1-IN 6 restores the immune response in a T cell-tumor co-culture model[1].

PD-1/PD-L1-IN-NP19
HY-131347	10 mg	EUR 1948.08
Description: PD-1/PD-L1-IN-NP19 is a PD-1/PD-L1 inhibitor, with an IC50 of 12.5 nM for human PD-1/PD-L1 interaction. PD-1/PD-L1-IN-NP19 could activate the immune microenvironment in tumor, which may contribute to its antitumor effects[1].

PD-1/PD-L1-IN-9
HY-132192	10 mg	EUR 984.86
Description: PD-1/PD-L1-IN-9 is a potent and orally active inhibitor of PD-1/PD-L1 interaction, with an IC50 of 3.8 nM. PD-1/PD-L1-IN-9 can enhance the killing activity of tumor cells by immune cells. PD-1/PD-L1-IN-9 also exhibits significant in vivo antitumor activity in a CT26 mouse model[1].

PD-1/PD-L1-IN-10
HY-132202	10 mg	EUR 779.23
Description: PD-1/PD-L1-IN-10 (compound B2) is an orally active PD-1/PD-L1 inhibitor (IC50 of 2.7 nM) with potent anticancer efficacy[1].

PD-1/PD-L1-IN-14
HY-144258	10 mg	EUR 2543.33
Description: PD-1/PD-L1-IN-14 (compound 17) is a bifunctional inhibitor of PD-1/PD-L1 interactions, with an IC50 of 27.8 nM. PD-1/PD-L1-IN-14 (compound 17) inhibits PD-1/PD-L1 interactions and promotes dimerization, internalization, and degradation of PD-L1[1].

PD-1/PD-L1-IN-15
HY-144442	Get quote	Ask for price
Description: PD-1/PD-L1-IN-15 (Compound M17) is a potent inhibitor of PD-1/PD-L1 with an IC50 value of 60.1 nM. PD-1/PD-L1-IN-15 has the potential for the research of tumor immunoresearch[1].

PD-1/PD-L1-IN-16
HY-144443	Get quote	Ask for price
Description: PD-1/PD-L1-IN-16 (Compound M23) is a potent inhibitor of PD-1/PD-L1 with an IC50 value of 53.2 nM. PD-1/PD-L1-IN-16 has the potential for the research of tumor immunoresearch[1].

PD-1/PD-L1-IN-17
HY-144447	Get quote	Ask for price
Description: PD-1/PD-L1-IN-17 (Compound P20) is a potent inhibitor of PD-1/PD-L1 with an IC50 value of 26.8 nM. PD-1/PD-L1-IN-17 is a promising lead compound for the development of inhibitors of the PD-1/PD-L1 interaction. PD-1/PD-L1-IN-17 has the potential for the research of cancer diseases[1].

PD-1/PD-L1-IN-24
HY-144649	Get quote	Ask for price
Description: PD-1/PD-L1-IN-24 is a highly potent PD-1/PD-L1 inhibitor with IC50 value of 1.57 nM. PD-1/PD-L1-IN-24 can restore T-cell function at the cellular level by significantly elevating the IFN-γ level. PD-1/PD-L1-IN-24 has low toxicity on the PBMCs[1].

PD-1/PD-L1-IN-26
HY-144746	Get quote	Ask for price
Description: PD-1/PD-L1-IN-26 (Compound II-14) is a potent inhibitor of PD-1/PD-L1 with an IC50 of 0.0380 μM. PD-1/PD-L1-IN-26 activates the immune microenvironment by promoting the infiltration of CD4+ T cells into tumor tissues. PD-1/PD-L1-IN-26 has the potential for the research of cancer diseases[1].

PD-1/PD-L1-IN-13
HY-145239	1 mg	EUR 3517.37
Description: PD-1/PD-L1-IN-13 (Compound 43) is a potent immune checkpoint PD-1/PD-L1 inhibitor with an IC50 value of 10.2 nM. PD-1/PD-L1-IN-13 promots CD8+ T cell activation and delays the tumor growth in the Hepa1-6 syngeneic mouse model[1].

PD-1/PD-L1-IN 5
HY-129172A	Get quote	Ask for price
Description: PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM[1].

PD-1/PD-L1-IN-36
HY-163041	Get quote	Ask for price
Description: PD-1/PD-L1-IN-36 (Compound 2k) is a PD-1/PD-L1 complex inhibitor (IC50: 15 nM). PD-1/PD-L1-IN-36 can be used for research of cancer immunotherapy[1].

PD-1/PD-L1-IN-25
HY-143305	Get quote	Ask for price
Description: PD-1/PD-L1-IN-25 (compound D2) is an inhibitor of PD-1/PD-L1 interaction with an IC50 value of 16.17 nM. PD-1/PD-L1-IN-25 activates the antitumor immunity of T cells efficiently in PBMCs. PD-1/PD-L1-IN-25 can be used for the research of cancer[1].

PD-1/PD-L1-IN-28
HY-148305	Get quote	Ask for price
Description: PD-1/PD-L1-IN-28 (compound 3) is an immune checkpoint inhibitor of PD-1/PD-L1 signaling pathway (IC50=0.744 µM). PD-1/PD-L1-IN-28 shows good research potential in tumor immunity[1].

PD-1/PD-L1-IN-31
HY-149356	Get quote	Ask for price
Description: PD-1/PD-L1-IN-31 is a PD-1/PD-L1 inhibitor (IC50=2.2 nM). PD-1/PD-L1-IN-31 promotes secretion of the IFN-γ, and induces immune activity of peripheral blood mononuclear cells (PBMCs) to inhibits tumor cells[1].

PD-1/PD-L1-IN-29
HY-152240	1 mg	EUR 919.93
Description: PD-1/PD-L1-IN-29 (S4-1) is a potent PD-1/PD-L1 inhibitor with an IC50 value of 6.1 nM. PD-1/PD-L1-IN-29 binds PD-L1 and disrupts PD-1/PD-L1 interactions, induces PD-L1 dimerization and internalization, improves its localization to the endoplasmic reticulum, and promotes PD-L1 entry into the endoplasmic reticulum. PD-1/PD-L1-IN-29 has anticancer activity[1].

PD-1/PD-L1-IN-34
HY-154869	Get quote	Ask for price
Description: PD-1/PD-L1-IN-34 (Compound (1S,2S)-A25) inhibits PD-1/PD-L1 interaction (IC50=0.029 μM), with a selected binding affinity with PD-L1 (KD=0.1554 μM). PD-1/PD-L1-IN-34 inhibits tumor growth by activating the immune microenvironment[1].

PD-1/PD-L1-IN-32
HY-155740	Get quote	Ask for price
Description: PD-1/PD-L1-IN-32 (compound A56) is a potent PD-1/PD-L1 inhibitor (IC50=2.4 nM), with anticancer activity. PD-1/PD-L1-IN-32 significantly inhibits tumor growth in hPD-L1 MC38 humanized mouse model, without obvious toxicity against mouse normal ability[1].

PD-1/PD-L1-IN-33
HY-155959	10 mg	EUR 1623.4
Description: PD-1/PD-L1-IN-33 (Compound N11) is a PD-1/PD-L1 inhibitor. PD-1/PD-L1-IN-33 inhibits PD-1 and PD-L1 interaction with an IC50: 6.3 nM. PD-1/PD-L1-IN-33 promotes T-cell proliferation, activation, and infiltration into tumor spheres. PD-1/PD-L1-IN-33 has immunomodulatory and anticancer activity[1].

PD 117519
585228	5.0mg	EUR 230

PD-166285
525796	5.0mg	EUR 275

PD 109488
525816	50.0mg	EUR 1340

PD 135158
525842	10.0mg	EUR 390

PD-176252
525902	10.0mg	EUR 400

PD-198306
525904	5.0mg	EUR 410

PD 146176
530393	10.0mg	EUR 250

PD 150606
531245	200.0mg	EUR 950

PD-85639
531389	5.0mg	EUR 250

PD-156707
532448	5.0mg	EUR 265

PD 158780
532449	10.0mg	EUR 470

PD 168368
532455	5.0mg	EUR 350

PD 180970
A8606-10	10 mg	EUR 302
Description: P210bcr/abl tyrosine kinase inhibitor

PD 169316
A8689-10	10 mg	EUR 72
Description: P38 MAPK inhibitor

PD 169316
A8689-5.1	10 mM (in 1mL DMSO)	EUR 106
Description: P38 MAPK inhibitor

PD 169316
A8689-50	50 mg	EUR 271
Description: P38 MAPK inhibitor

PD 173074
A8253-10	10 mg	EUR 40
Description: FGFR inhibitor

PD 173074
A8253-5.1	10 mM (in 1mL DMSO)	EUR 48
Description: FGFR inhibitor

PD 173074
A8253-50	50 mg	EUR 112
Description: FGFR inhibitor

PD 173074
A8253-S	Evaluation Sample	EUR 22
Description: FGFR inhibitor

PD-173212
598025	5.0mg	EUR 375

PD-166793
598116	10.0mg	EUR 360

PD 98059
1666-5	each	EUR 189.6

PD 173074
1675-1	each	EUR 164.4

PD 173074
1675-100	each	Ask for price

PD 150,606
1906-25	each	EUR 444

PD 150,606
1906-5	each	EUR 164.4

PD 173074
27056	10 mg	EUR 125
Description: PD 173074 inhibited the kinase activity of FGFR1 with an IC50 of 25 nM in vitro, while inhibiting Src, the receptors for insulin, epidermal growth factor (EGF) and PDGF, and several serine/threonine kinases with 1000-fold or higher IC50 values. PD 173074 was an ATP-competitive inhibitor of FGFR1, with a Ki of around 40 nM. PD 173074 inhibited autophosphorylation of FGFR1 and VEGFR2 in a dose-dependent manner with IC50s in the range of 1-5 nM and 100-200 nM, respectively.

PD 082106
461981	5.0mg	EUR 300

PD 124966
414279	500.0µg	EUR 355

PD 81723
414815	10.0mg	EUR 335

PD-168393
406105	25.0mg	EUR 300

PD-0325901